RE:RE:RE:RE:RE:RE:RE:Trodelvy improved PFS by 34% in heavily pre-treated patients Trodelvy has a Boxed Warning for severe or life-threatening neutropenia and severe diarrhea, and is a serious consideration in the the FDA's decisions involving the granting an Accelerated Approval. In contrast, ONCY's pelareorep has not such warnings and has demonstrated a minimal side effect profile in over 1000 patients who've been treated with the drug. In otherwords pelareorep is "Safe and Effective", which is to the consternation of some who continually decry the benefits of pelareorep on this and other message boards. https://www.bloomberg.com/press-releases/2023-02-03/u-s-fda-approves-trodelvy-in-pre-treated-hr-her2-metastatic-breast-cancer